Renzapride (hydrochloride)
Renzapride hydrochloride is a benzamide that inhibits irritable bowel syndrome and has antagonistic activity at 5-HT (3) receptors and agonistic activity at 5-HT (4) receptors. Renzapride hydrochloride also exhibits antagonistic activity at 5-HT (2B) receptors and has a certain affinity for 5-HT (2A) and 5-HT (2C) receptors[1].
Product Specifications
CAS Number
[109872-41-5]
UNSPSC
12352005
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/renzapride-hydrochloride.html
Smiles
ClC1=C(N)C=C(OC)C(C(N[C@H]2CCN3CCC[C@@H]2C3)=O)=C1.Cl
Molecular Formula
C16H23Cl2N3O2
Molecular Weight
360.28
References & Citations
[1]Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
5-HT2 Receptor
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal mGluR5/1a Antibody (S75-33) [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
GCK (Glucokinase, Hexokinase Type IV, HK IV, Hexokinase-4, HK4, Hexokinase-D, GCK)
GCK (Glucokinase, Hexokinase Type IV, HK IV, Hexokinase-4, HK4, Hexokinase-D, GCK)
